Erratum. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018;41;1299-1311.
作者信息
Cefalu William T, Dawes Daniel E, Gavlak Gina, Goldman Dana, Herman William H, Van Nuys Karen, Powers Alvin C, Taylor Simeon I, Yatvin Alan L
出版信息
Diabetes Care. 2018 Aug;41(8):1831. doi: 10.2337/dc18-er08. Epub 2018 Jun 28.
Abstract
摘要
相似文献
1
Erratum. Insulin Access and Affordability Working Group: Conclusions and Recommendations. Diabetes Care 2018;41;1299-1311.
Diabetes Care. 2018 Aug;41(8):1831. doi: 10.2337/dc18-er08. Epub 2018 Jun 28.
2
Insulin Access and Affordability Working Group: Conclusions and Recommendations.
Diabetes Care. 2018 Jun;41(6):1299-1311. doi: 10.2337/dci18-0019. Epub 2018 May 8.
3
Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study.
Lancet Diabetes Endocrinol. 2018 Oct;6(10):798-808. doi: 10.1016/S2213-8587(18)30233-X. Epub 2018 Aug 28.
4
Medicare health maintenance organizations and traditional coverage: perceptions of health care among beneficiaries with disabilities.
Arch Phys Med Rehabil. 2001 Aug;82(8):1009-17. doi: 10.1053/apmr.2001.25135.
5
Looking beyond the issue of access to insulin: what is needed for proper diabetes care in resource poor settings.
Diabetes Res Clin Pract. 2010 Jun;88(3):217-21. doi: 10.1016/j.diabres.2010.03.029. Epub 2010 May 5.
6
Access to diabetes care and treatment in Africa : challenges and opportunities.
Med Sante Trop. 2018 Nov 1;28(4):351-354. doi: 10.1684/mst.2018.0832.
7
Constraints and challenges in access to insulin: a global perspective.
Lancet Diabetes Endocrinol. 2016 Mar;4(3):275-285. doi: 10.1016/S2213-8587(15)00521-5. Epub 2016 Feb 6.
8
Availability and Affordability of Essential Medicines: Implications for Global Diabetes Treatment.
Curr Diab Rep. 2018 Jun 16;18(8):48. doi: 10.1007/s11892-018-1019-z.
9
Patterns in Health Care Access and Affordability Among Cancer Survivors During Implementation of the Affordable Care Act.
JAMA Oncol. 2018 Jun 1;4(6):791-797. doi: 10.1001/jamaoncol.2018.0097.
10
Access To Care And Affordability Have Improved Following Affordable Care Act Implementation; Problems Remain.
Health Aff (Millwood). 2016 Jan;35(1):161-8. doi: 10.1377/hlthaff.2015.0755. Epub 2015 Dec 16.
引用本文的文献
1
17. Diabetes Advocacy: Standards of Care in Diabetes-2025.
Diabetes Care. 2025 Jan 1;48(Supplement_1):S335-S336. doi: 10.2337/dc25-S017.
2
1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2025.
Diabetes Care. 2025 Jan 1;48(Supplement_1):S14-S26. doi: 10.2337/dc25-S001.
3
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2024.
Diabetes Care. 2024 Jan 1;47(Suppl 1):S158-S178. doi: 10.2337/dc24-S009.
4
1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2024.
Diabetes Care. 2024 Jan 1;47(Suppl 1):S11-S19. doi: 10.2337/dc24-S001.
5
Real-World Persistence, Adherence, Hypoglycemia, and Health Care Resource Utilization in People With Type 2 Diabetes Who Continued With the Second-Generation Basal Insulin Analog Insulin Glargine 300 Units/mL or Switched to a First-Generation Basal Insulin (Insulin Glargine 100 Units/mL or Detemir 100).
Clin Diabetes. 2023 Summer;41(3):425-434. doi: 10.2337/cd22-0096. Epub 2023 Mar 28.
6
Survey Reveals Patient and Health Care Provider Experiences and Challenges With the Use of High Doses of Basal Insulin.
Clin Diabetes. 2023 Spring;41(2):244-257. doi: 10.2337/cd22-0062. Epub 2022 Dec 6.
7
The National Clinical Care Commission Report to Congress: Recommendations to Better Leverage Federal Policies and Programs to Prevent and Control Diabetes.
Diabetes Care. 2023 Feb 1;46(2):255-261. doi: 10.2337/dc22-1587.
8
9. Pharmacologic Approaches to Glycemic Treatment: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Suppl 1):S140-S157. doi: 10.2337/dc23-S009.
9
1. Improving Care and Promoting Health in Populations: Standards of Care in Diabetes-2023.
Diabetes Care. 2023 Jan 1;46(Supple 1):S10-S18. doi: 10.2337/dc23-S001.
10
A Cross-Sectional Study of Quality of Life Among Brazilian Adults With Type 1 Diabetes Treated With Insulin Glargine: Findings and Implications.
Clin Diabetes. 2022 Summer;40(3):312-326. doi: 10.2337/cd21-0068.
Zotero 插件